Pfizer reups PPD deal in a contract research pact spree

Pfizer has always been a heavy user of CROs, and over the past few months it’s been ramping up its partnerships.

Last month, it doubled down on its existing pact with Syneos Health (the results of the INC Research and inVentiv Health merger in 2018), a few months after signing a similar deal with Icon; now it’s doing the same with PPD.